Browsing by Author "Mattos, Mayara"
Now showing items 1-16 of 16
-
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2020 -
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2Mpro, Impairing Variants Replication In Vitro and In Vivo
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
Rodrigues, Natalia Fintelman et al. | Date Issued: 2020 -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2020 -
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
Ferreira, André C. et al. | Date Issued: 2019 -
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Sacramento, Carolina Q. et al. | Date Issued: 2021 -
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, Suelen da Silva Gomes et al. | Date Issued: 2020 -
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Souza, Thiago Moreno L. et al. | Date Issued: 2023O artigo trata do desenvolvimento de um antiviral de uso oral contra a Covid-19. A substância, batizada de MB-905, foi purificada a partir da cinetina e demonstrou-se eficaz para inibir a replicação do Sars-CoV-2 em linhagens ... -
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, André C. et al. | Date Issued: 2021 -
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, Lívia et al. | Date Issued: 2022 -
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
Ferreira, André C. et al. | Date Issued: 2017 -
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
Sacramento, Carolina Q. et al. | Date Issued: 2022 -
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
Sacramento, Carolina Q. et al. | Date Issued: 2021 -
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
Temerozo, Jairo R. et al. | Date Issued: 2022 -
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Freitas, Caroline S. de et al. | Date Issued: 2019